Skip to main content

Table 1 Patients’ demographic data

From: Is preoperative protein-rich nutrition effective on postoperative outcome in non-small cell lung cancer surgery? A prospective randomized study

  

Control group

Nutrition group

Total

P value

Agea

 

59.04 ± 7.61/year

57.80 ± 9.70/year

58.35 ± 8.8/year

0.482

Sex

Male

25 (92.6 %)

29 (93.5 %)

54 (93.1 %)

1

Female

2 (7.4 %)

2 (6.5 %)

4(6.9 %)

 

FEV-1a

 

74.5 ± 15.01 %

71.55 ± 15.52 %

72.84 ± 15.23 %

0.594

BMI

Thoracotomy

26.7 ± 4.20

24.0 ± 3.69

25.21 ± 4.11

0.051

VATS

26.6 ± 2.26

27.3 ± 4.19

26.92 ± 3.31

0.632

Total

26.7 ± 3.49

25.2 ± 4.13

25.86 ± 3.88

0.138

Operation Type

Thoracotomy

16 (59.3 %)

20 (64.5 %)

36 (62.06 %)

0.788

VATS

11 (40.7 %)

11 (35.5 %)

22 (37.94 %)

 

Resection Type

LUL

5 (18.52 %)

9 (29.03 %)

14 (24.14 %)

0.788

LLL

4 (14.81 %)

6 (19.35 %)

10 (17.24 %)

 

RLL

5 (18.52 %)

6 (19.35 %)

11 (18.97 %)

 

L-P

2 (7.41 %)

5 (16.13 %)

7 (12.07 %)

 

RUL

8 (29.63 %)

3 (9.68 %)

11 (18.97 %)

 

RSBL

2 (7.41 %)

2 (6.45 %)

4 (6.89 %)

 

RIBL

1 (3.7 %)

 

1 (1.72 %)

 

Drainage Timeb

 

6 (42–1)/day

4 (15–2)/day

4.9 ± 2.26/day

0.019

Complication

PAL

7 (58.33 %)

4 (66.67 %)

11 (18 %)

 

Atelectasis

3 (25 %)

1 (16.67 %)

4 (6.8 %)

 

Pneumonia

1 (8.33 %)

1 (16.67 %)

2 (3.4 %)

 

Arhytmia

1 (8.33 %)

 

1 (1.7 %)

 

Total

12 (44.4 %)

6 (19.4 %)

18 (31.04 %)

0.049

 

AC

17 (62.96 %)

12 (38.71 %)

27 (46.55 %)

0.122

Histology

SCC

9 (33.33 %)

18 (58.06 %)

27 (46.55 %)

 
 

Carcinoid

1 (3.7 %)

1 (3.23 %)

2 (6.9 %)

 

Stage

IA

7 (25.93 %)

11 (35.48 %)

18 (31.04 %)

0.608

 

IB

6 (22.22 %)

3 (9.68 %)

9 (15.52 %)

 
 

IIA

8 (29.63 %)

7 (22.58 %)

15 (25.86 %)

 
 

IIB

3 (11.11 %)

6 (19.35 %)

9 (15.52 %)

 
 

IIIA

3 (11.11 %)

4 (12.9 %)

7 (12.06 %)

 

Concomitant Diseases

Hypertension

4 (44.44 %)

5 (38.46 %)

9 (40.91 %)

 

COPD

 

3 (23.08 %)

3 (13.64 %)

 

CAD

 

2 (15.38 %)

2 (9.09 %)

 

MNG

2 (22.22 %)

1 (7.69 %)

3 (13.64 %)

 

CHF

 

1 (7.69 %)

1 (4.55 %)

 

Asthma

 

1 (7.69 %)

1 (4.55 %)

 

AS

1 (11.11 %)

 

1 (4.55 %)

 

Parkinson

1 (11.11 %)

 

1 (4.55 %)

 

PVD

1 (11.11 %)

 

1 (4.55 %)

 

Total

9 (33.3 %)

13 (41.9 %)

22 (37.9 %)

0.592

  1. Pearson Chi-Square Test (Monte Carlo) - Mann Whitney U Test (Monte Carlo) - Independent T Test (Bootstrap)
  2. aMean ± SD, bMedyan Range (Maximum- Minimum), n (%)
  3. BMI: Body Mass Index; VATS: Video-assisted thoracoscopic surgery; LUL: Left Upper Lobectomy; LLL: Left Lower Lobectomy; RLL: Right Lower Lobectomy; L-P: Left Pneumonectomy; RUL: Right Upper Lobectomy; RSBL: Right Superior Bilobectomy; RIBL: Right İnferior Bilobectomy; PAL: Prolonged Air Leak; AC: Adenocarcinoma; SCC: Squamous Cell Carcinoma; CAD: Coronary Artery Disease; COPD: Chronic obstructive pulmonary disease; MNG: Multinodular goiter; CHF: Congestive heart failure; AS: Ankylosing spondylitis; PVD: Peripheral vessel disease